Johnson & Johnson (JNJ) announced that the FDA has granted Fast Track designation to its Posdinema, a monoclonal antibody ...

Additionally, the Phase 1 clinical trial evaluating QTX3034, an oral G12D-preferring multi-KRAS inhibitor, as a monotherapy and in combination with cetuximab, continues to enroll patients, and data is ...

The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...

In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about ...

North Carolina-based Blue Ridge Beef is recalling more than 1,300 pounds of cat food over salmonella contamination following ...

We cannot let individuals who prey on vulnerable people and who seek to do harm access our country through systems meant to ...

A man arrested in a 2023 drug bust by the Walla Walla Regional Drug and Gang Task Force was sentenced to 19 years and seven ...

Solid Biosciences received clearance from the Food and Drug Administration for an investigational new drug application, the company said Tuesday.

It was a really triggering moment for me because there were a lot of things I discovered in our closet that I did not know existed,” the dancer admitted.

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

It was a landmark year for medical advancements in 2024, bringing a wave of innovative treatments that promise to reshape ...